Sector revisions Novartis AG Mexican S.E.

Stocks

End-of-day quote Mexican S.E. 2026-09-25			5-day change	1st Jan Change
2,572.00 ^MXN	+5.24%		+5.24%	+2.88%

08:24am	Merck's experimental skin disease drug succeeds in mid-stage study	RE
08:20am	Major drugmakers turn to China for licensing deals	RE

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							22
	ABBVIE INC.							28
	MERCK & CO., INC.							25
	ROCHE HOLDING AG							19
	NOVARTIS AG							22
	ASTRAZENECA PLC							23
	AMGEN INC.							29
	GILEAD SCIENCES, INC.							26
	NOVO NORDISK A/S							23
	PFIZER INC.							26
	VERTEX PHARMACEUTICALS INCORPORATED							28
	BRISTOL-MYERS SQUIBB COMPANY							24
	MCKESSON CORPORATION							14
	GSK PLC							21
	SANOFI							24
	MODERNA, INC.							18
	REGENERON PHARMACEUTICALS, INC.							26
	MERCK KGAA							14
	Average							23
	Weighted average by Cap.							25